» Articles » PMID: 27382020

A Nonoligomerizing Mutant Form of Helicobacter Pylori VacA Allows Structural Analysis of the P33 Domain

Abstract

Helicobacter pylori secretes a pore-forming VacA toxin that has structural features and activities substantially different from those of other known bacterial toxins. VacA can assemble into multiple types of water-soluble flower-shaped oligomeric structures, and most VacA activities are dependent on its capacity to oligomerize. The 88-kDa secreted VacA protein can undergo limited proteolysis to yield two domains, designated p33 and p55. The p33 domain is required for membrane channel formation and intracellular toxic activities, and the p55 domain has an important role in mediating VacA binding to cells. Previous studies showed that the p55 domain has a predominantly β-helical structure, but no structural data are available for the p33 domain. We report here the purification and analysis of a nonoligomerizing mutant form of VacA secreted by H. pylori The nonoligomerizing 88-kDa mutant protein retains the capacity to enter host cells but lacks detectable toxic activity. Analysis of crystals formed by the monomeric protein reveals that the β-helical structure of the p55 domain extends into the C-terminal portion of p33. Fitting the p88 structural model into an electron microscopy map of hexamers formed by wild-type VacA (predicted to be structurally similar to VacA membrane channels) reveals that p55 and the β-helical segment of p33 localize to peripheral arms but do not occupy the central region of the hexamers. We propose that the amino-terminal portion of p33 is unstructured when VacA is in a monomeric form and that it undergoes a conformational change during oligomer assembly.

Citing Articles

Taurine modulates host cell responses to VacA toxin.

Westland M, Schrimpe-Rutledge A, Codreanu S, Sherrod S, McLean J, McClain M Infect Immun. 2024; 92(8):e0022424.

PMID: 38975764 PMC: 11320975. DOI: 10.1128/iai.00224-24.


There Are No Insurmountable Barriers: Passage of the VacA Toxin from Bacterial Cytoplasm to Eukaryotic Cell Organelle.

Jarzab M, Skorko-Glonek J Membranes (Basel). 2024; 14(1).

PMID: 38248700 PMC: 10821523. DOI: 10.3390/membranes14010011.


Structural Analysis of Membrane-associated Forms of Helicobacter pylori VacA Toxin.

Connolly S, Erwin A, Sabb M, Hanks J, Chang L, Torrez R J Mol Biol. 2023; 436(4):168432.

PMID: 38161000 PMC: 11090358. DOI: 10.1016/j.jmb.2023.168432.


Therapeutic properties of Helicobacter pylori-derived vacuolating cytotoxin A in an animal model of chronic allergic airway disease.

Raspe J, Schmitz M, Barbet K, Caso G, Cover T, Muller A Respir Res. 2023; 24(1):178.

PMID: 37415170 PMC: 10324189. DOI: 10.1186/s12931-023-02484-5.


Treatment with -derived VacA attenuates allergic airway disease.

Reuter S, Raspe J, Uebner H, Contoyannis A, Pastille E, Westendorf A Front Immunol. 2023; 14:1092801.

PMID: 36761723 PMC: 9902502. DOI: 10.3389/fimmu.2023.1092801.


References
1.
Czajkowsky D, Iwamoto H, Cover T, Shao Z . The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc Natl Acad Sci U S A. 1999; 96(5):2001-6. PMC: 26726. DOI: 10.1073/pnas.96.5.2001. View

2.
Ye D, Willhite D, Blanke S . Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J Biol Chem. 1999; 274(14):9277-82. DOI: 10.1074/jbc.274.14.9277. View

3.
Iwamoto H, Czajkowsky D, Cover T, Szabo G, Shao Z . VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett. 1999; 450(1-2):101-4. DOI: 10.1016/s0014-5793(99)00474-3. View

4.
Reyrat J, Lanzavecchia S, Lupetti P, De Bernard M, Pagliaccia C, Pelicic V . 3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin. J Mol Biol. 1999; 290(2):459-70. DOI: 10.1006/jmbi.1999.2877. View

5.
Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford J . Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 1999; 18(20):5517-27. PMC: 1171620. DOI: 10.1093/emboj/18.20.5517. View